Back
EHRA 2024 Premium Access

A propensity score matched comparison of pulsed field versus hybrid ablation in patients with long standing persistent atrial fibrillation

Session: Atrial fibrillation: treatment 2
Topic: Rhythm Control, Hybrid Therapy
Speaker: Doctor I. Doundoulakis (Brussels, BE)
Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Ioannis Doundoulakis

Vrije University Brussels, Brussels (Belgium)
0 follower

8 more presentations in this session

Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.

Speaker: Ms C. van der Heijden (Maastricht, NL)

Access
Abstract
Slides
Video
Thumbnail

Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.

Speaker: Miss L. Aerts (Maastricht, NL)

Access
Abstract
Slides
Video
Thumbnail

Intra-procedural three-dimensional rotational angiography in cryoballoon ablation of atrial fibrillation - results from a randomised clinical trial

Speaker: Doctor I. Prepolec (Zagreb, HR)

Access
Abstract
Slides
Video
Thumbnail

The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution

Speaker: Doctor V. Lim (Coventry, GB)

Access
Abstract
Slides
Video
Thumbnail

LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial

Speaker: Doctor I. Romanazzi (Acquaviva Delle Fonti, IT)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Atrial fibrillation: treatment 2

Speakers: Doctor I. Doundoulakis, Ms C. van der Heijden, Miss L. Aerts, Doctor I. Prepolec, Doctor V. Lim...
Access
Thumbnail

About the event

Image

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb